![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2019
Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Duerig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco und Hopfinger, Georg
(2019):
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.
In: Leukemia & Lymphoma, Bd. 60, Nr. 3: S. 649-657
2018
Busygina, Kristina; Jamasbi, Janina; Seiler, Till; Deckmyn, Hans; Weber, Christian; Brandl, Richard; Lorenz, Reinhard und Siess, Wolfgang
(2018):
Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans.
In: Blood, Bd. 131, Nr. 24: S. 2605-2616
Cramer, Paula; Tresckow, Julia von; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara und Hallek, Michael
(2018):
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
In: Lancet Oncology, Bd. 19, Nr. 9: S. 1215-1228
2017
Fischer, Kirsten; Al-Sawaf, Othman; Fink, Anna-Maria; Dixon, Mark; Bahlo, Jasmin; Warburton, Simon; Kipps, Thomas J.; Weinkove, Robert; Robinson, Sue; Seiler, Till; Opat, Stephen; Owen, Carolyn; Lopez, Javier; Humphrey, Kathryn; Humerickhouse, Rod; Tausch, Eugen; Frenzel, Lukas; Eichhorst, Barbara; Wendtner, Clemens-M.; Stilgenbauer, Stephan; Langerak, Anton W.; Dongen, Jacque J. M. van; Böttcher, Sebastian; Ritgen, Matthias; Göde, Valentin; Mobasher, Mehrdad und Hallek, Michael
(2017):
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
In: Blood, Bd. 129, Nr. 19: S. 2702-2705
2016
Seiler, Till; Hutter, Grit und Dreyling, Martin
(2016):
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.
In: Drugs, Bd. 76, Nr. 6: S. 639-646
2009
Seiler, Till und Hiddemann, Wolfgang
(2009):
Microenvironmental Influences and Antigenic Stimulation in Chronic Lymphocytic Leukemia.
In: Onkologie, Nr. 10: S. 550-551
[PDF, 56kB]